Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

A preprint of ongoing work to assess effectiveness of Oxford’s ChAdOx1 coronavirus vaccine shows that the existing vaccine has similar efficacy against the B.1.1.7 ‘Kent’ coronavirus strain currently circulating in the UK to previously circulating variants.

Researcher processing serum in the lab © Credit: University of Oxford, John Cairns

Design, validation, and functional impact of oligonucleotides for multigene silencing in Alzheimer's disease.

Journal article

Woffindale C. et al, (2026), Mol Ther Nucleic Acids, 37

Structure-guided design of a PfCyRPA-based vaccine against blood-stage malaria.

Journal article

Alam N. et al, (2026), EMBO Mol Med

Broad lessons from negative trials in rare diseases.

Journal article

Servais L. and Oskoui M., (2026), Lancet Neurol, 25, 215 - 217

Securing the future of immunisation: ESCMID’s vision

Journal article

Ramasamy MN. et al, (2026), CMI Communications, 3, 105167 - 105167

Load More